Oncopeptides withdraws Pepaxto® in US, scale down organization and focus on R&D ...

Retrieved on: 2021-10-23 15:26:48

Tags for this article:

Click the tags to see associated articles and topics

Oncopeptides withdraws Pepaxto® in US, scale down organization and focus on R&D .... View article details on hiswai:

Excerpt

STOCKHOLM, Sweden I October 22, 2021 I Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of ...

Article found on: pipelinereview.com